How to administer Nitroglycerin (NTG) for angina symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Administer Nitroglycerin (NTG) for Angina

For acute angina, place one sublingual tablet (0.3-0.6 mg) under the tongue at the first sign of chest pain, repeat every 5 minutes for up to 3 doses total, and call 9-1-1 immediately if pain persists after the first dose or worsens. 1, 2

Sublingual Administration for Acute Angina

Initial Dosing

  • Dissolve one tablet (0.3-0.6 mg) under the tongue or in the buccal pouch at the first sign of anginal attack 2
  • Do not chew, crush, or swallow the tablet 2
  • Patient should sit down during administration to prevent falls from lightheadedness or dizziness 2

Repeat Dosing Protocol

  • If chest pain is unimproved or worsening 5 minutes after the first dose, call 9-1-1 immediately 1, 3
  • While waiting for emergency services, repeat NTG every 5 minutes up to a maximum of 3 doses total 1, 2
  • If pain persists after 3 tablets in a 15-minute period, or if the pain is different than typically experienced, this represents a medical emergency requiring immediate professional attention 3, 2

Important Distinction for Chronic Stable Angina Patients

The ACC/AHA guidelines make a critical distinction: for patients with known chronic stable angina whose symptoms are significantly improved after one dose, it is appropriate to repeat NTG every 5 minutes for up to 3 doses and call 9-1-1 only if symptoms have not totally resolved 1. However, this more permissive approach should only apply to patients with well-characterized, frequent angina patterns—not to new or worsening symptoms.

Prophylactic Use

  • Administer 5-10 minutes prior to activities that might precipitate an acute attack 2
  • This preemptive dosing can prevent exercise-induced angina 4

Critical Contraindications

  • Absolute contraindication: Do not give NTG if patient has used sildenafil within 24 hours, tadalafil within 48 hours, or vardenafil (timing uncertain, but generally 24 hours) 1, 5
  • These phosphodiesterase-5 inhibitors can cause profound hypotension, MI, and death when combined with nitrates 1, 5
  • Avoid if systolic blood pressure <90 mmHg or >30 mmHg below baseline 1, 5
  • Avoid with marked bradycardia or tachycardia 1, 5

Intravenous NTG for Refractory Angina

When to Initiate IV NTG

  • For patients with persistent chest pain after 3 sublingual doses or ongoing refractory ischemic symptoms in the hospital setting 5, 3

IV Dosing Protocol

  • Start at 10 mcg/min via continuous infusion through non-absorbing tubing 1, 5
  • Increase by 10 mcg/min every 3-5 minutes until symptom relief or blood pressure response 1, 5
  • If no response at 20 mcg/min, continue with 10 mcg/min increments, then switch to 20 mcg/min increments for more aggressive titration 1, 5
  • Although a ceiling of 200 mcg/min is commonly used, doses up to 300-400 mcg/min have been shown to be safe and effective for optimal afterload reduction 5, 6
  • Even prolonged infusion at 300-400 mcg/min for 2-4 weeks does not increase methemoglobin levels 1, 5

Blood Pressure Targets During IV Infusion

  • Do not reduce systolic BP below 110 mmHg in previously normotensive patients 1, 5
  • In hypertensive patients, do not reduce mean arterial pressure by more than 25% below baseline 1, 5

Tolerance Considerations

  • Tolerance to hemodynamic effects typically develops after 24 hours of continuous therapy 1, 5, 7
  • For patients requiring NTG beyond 24 hours, periodic dose increases may be needed to maintain efficacy 1, 5
  • When patients are symptom-free for 12-24 hours, attempt to reduce IV dose and transition to oral/topical nitrates 1, 5

Alternative Formulations

NTG Spray

  • Delivers 0.4 mg per spray, with similar efficacy to sublingual tablets 4
  • Superior to sublingual tablets in patients with dry mouth, as it does not require saliva for dissolution 8
  • Onset of action and duration similar to sublingual tablets 1

Long-Acting Nitrates (Oral/Transdermal)

  • Acceptable for patients requiring chronic antianginal therapy but without ongoing refractory symptoms 1
  • Use intermittent dosing strategies (12-14 hours on, 10-12 hours off) to prevent tolerance 1, 5, 7
  • Transdermal patches ≥10 mg/24h provide effective nitrate effects but lose efficacy by 24 hours with continuous use 7

Common Pitfalls to Avoid

Patient Self-Medication Delays

  • Self-treatment with NTG is a documented cause of delay in seeking emergency care 1
  • Patients must understand that taking multiple NTG doses without calling 9-1-1 can worsen outcomes 1, 3

Storage and Potency

  • Keep NTG in the original glass container, tightly capped after each use to prevent loss of potency 2
  • The burning or tingling sensation under the tongue is NOT a reliable indicator of tablet potency 2

Drug Interactions

  • Concomitant alcohol use may potentiate hypotension 2
  • Tricyclic antidepressants and anticholinergics cause dry mouth, which may impair sublingual tablet dissolution—consider NTG spray in these patients 2, 8

Side Effects

  • Headache is common and may indicate drug activity 2
  • Hypotension-induced paradoxical bradycardia can worsen angina 2
  • Excessive dosing can produce severe headaches 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Persistent Chest Pain After Three Nitroglycerin Tablets

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nitroglycerin Dosing in Sympathetic Crashing Acute Pulmonary Edema (SCAPE)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Transdermal nitroglycerin in angina pectoris.

European heart journal, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.